Health
UNDERREPORTED
Cancer drug shortages persist at US treatment centers, survey shows
A new survey reveals that every major US cancer center is facing a shortage of at least one oncology medication, with many reporting multiple gaps.
The National Comprehensive Cancer Network surveyed its 34 member centers and found that all are experiencing shortages of cancer drugs, and over one-fifth report five or more missing medicines. While 61% say they can still treat patients, they must limit waste, reduce inventory use, and often give the lowest recommended doses. Two-thirds note that these gaps cause treatment delays because insurers require renewed prior authorizations.
Why it matters
Drug shortages force clinicians to alter cancer treatment, potentially compromising patient outcomes and trial progress.
In this story
cancer drug shortageoncology medicationtreatment delaysclinical trial disruptionprior authorizationUS cancer centers
